Clinical Trials Browser

Azacitidine × Tumor-Agnostic × 30 days × Clear all

NCT07404332 2026-05-28

5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

Phase 1 Recruiting

Neoplasm Metastasis